Development of a high-affinity inhibitor of the prostaglandin transporter

Medicine & Life Sciences

• Prostaglandin Antagonists 100%
• Prostaglandins E 89%
• Prostaglandins 50%
• N-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-4-((4-((2-(2-(2-benzamidoethoxy)ethoxy)ethyl)amino)-6-((4-hydroxyphenyl)amino)-1,3,5-triazin-2-yl)amino)benzamide 17%
• Organic Anion Transporters 9%
• Madin Darby Canine Kidney Cells 8%
• Patent Ductus Arteriosus 8%
• Structure-Activity Relationship 7%
• Drug Delivery Systems 6%
• Dinoprostone 6%
• Knockout Mice 6%
• Half-Life 5%
• Animals 3%
• Therapeutics 1%